Clinical Trial Update: Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

View source ↗

Summary

The clinical trial investigating the LDL-C to HDL-C ratio improvement after statin therapy in Korean patients with dyslipidemias has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemias | Status: COMPLETED